BIOSerenity in the news
Chronic Disease Monitoring Solutions
Tamtam found 20 recent articles about BIOSerenity.
- Désertification médicale en Villeneuvois : et si la solution du médecin salarié venait du centre du sommeil au Pôle santé ?
Aqodi is expanding its salaried physician model in the Villeneuvois region after taking over a sleep center previously managed by BioSerenity.
- IoT santé : les objets connectés transforment la santé et la médecine | Big média | S’inspirer, S’informer, S’engager
Connected medical devices and IoT technologies are revolutionizing patient monitoring and preventive medicine through real-time data collection and remote supervision.
- Ouverture d’une clinique du sommeil à Saint-Dizier
BioSerenity launched its eighth sleep clinic at the Saint-Dizier hospital center to treat referred patients.
- BioSerenity : l’encéphalogramme redémarre
BioSerenity has been revitalized by Jolt Capital to specialize in AI-assisted remote EEG monitoring and has launched a new manufacturing facility in France.
- Troubles du sommeil, épilepsie… BioSerenity concilie IA et électroencéphalogrammes pour améliorer les diagnostics
BioSerenity has pivoted to AI-powered neurological diagnostics and local manufacturing following a strategic restructuring by Jolt Capital.
- Fermeture du bureau américain, recentrage stratégique… le plan de la start-up BioSerenity un an après sa reprise
BioSerenity is refocusing on neurology and modernizing its infrastructure following a 27 million euro capital injection from Jolt Capital.
- BioSerenity, une grande start-up médicale française au tapis
BioSerenity, a leading French MedTech startup specializing in electrophysiology diagnostics and chronic disease monitoring, has collapsed.
- BioSerenity se mobilise aux côtés de l'INSV pour sensibiliser les Français sur les troubles du sommeil
BioSerenity partners with the INSV to provide sleep disorder diagnostics and public awareness workshops for patients suffering from insomnia and apnea.
- BioSerenity Receives Major Funding Boost to Expand AI-Driven Medical Tech
BioSerenity raised 24 million Euros from Jolt Capital to expand its AI-based neurology and sleep disorder diagnostic tools globally.
- La medtech française Bioserenity sauvée de la liquidation par Jolt Capital pour 24 millions d’euros
Jolt Capital rescued BioSerenity from liquidation with a 24 million euro investment to refocus its connected EEG diagnostics business.
- French medtech BioSerenity bags €24M to help doctors use AI for diagnoses
BioSerenity raised 24 million euros to scale its AI-powered medical wearable devices and diagnostic services across international markets.
- FT 120 : BioSerenity repris par le fonds Jolt Capital
BioSerenity, a French startup in chronic disease monitoring solutions, was acquired by Jolt Capital after entering judicial reorganization.
- Grand Est. Un centre BioSerenity à l'hôpital de Mercy : éveiller le public aux troubles du sommeil
A BioSerenity center at Mercy Hospital in Grand Est is raising public awareness about common sleep disorders, exemplified by a local resident's struggles.
- BIOSERENITY en passe d’être repris, mais par qui? Les actus tech qu'il ne faut pas manquer ce matin.
BioSerenity is undergoing a court-ordered takeover process with three competing bidders vying to acquire its medical monitoring assets and absorb its significant debt.
- [Archive] 👩⚕️👨⚕️ Bioserenity réalise la 1ère démonstration du challenge 5G Issy/Orange
BioSerenity successfully demonstrated real-time remote EEG monitoring using 5G technology at a nursing home to prove medical exams can be decentralized.
- SCOR makes follow-on investment in BioSerenity
SCOR has made a follow-on investment in BioSerenity, a medical technology company providing remote diagnostic solutions for neurology, sleep, and cardiology.
- Grand Nancy. BioSerenity, le sommeil, c’est son affaire
BioSerenity, initially focused on cardiology and neurology, expanded into sleep medicine, a neglected area in French healthcare.
- A Dijon, BioSerenity intègre un Groupement d’Intérêt Scientifique public-privé sur la rééducation par l’intelligence artificielle
BioSerenity joins a public-private partnership in Dijon to develop AI-powered medical devices and services for neurological rehabilitation and patient monitoring.
- WeHealth™ Digital Medicine and BioSerenity Initiate a New Phase to Accelerate Cardioskin™ Commercialization
BioSerenity acquires global distribution rights for the Cardioskin wearable ECG device to expand its remote cardiology services internationally.
- BioSerenity receives FDA clearance for EEG wearable device system
BioSerenity received FDA clearance for its Neuronaute and IceCap wearable EEG system designed for remote epilepsy monitoring.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like BIOSerenity?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies